MEDICAL PROGRESS - THE PRIMARY PREVENTION OF MYOCARDIAL-INFARCTION

被引:451
作者
MANSON, JE
TOSTESON, H
RIDKER, PM
SATTERFIELD, S
HEBERT, P
OCONNOR, GT
BURING, JE
HENNEKENS, CH
机构
[1] BRIGHAM & WOMENS HOSP, DEPT MED, CHANNING LAB, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, DEPT PREVENT MED, BOSTON, MA 02115 USA
[3] DARTMOUTH COLL, HITCHCOCK MED CTR, DEPT MED, HANOVER, NH 03756 USA
关键词
D O I
10.1056/NEJM199205213262107
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IN the United States, coronary heart disease — principally myocardial infarction — accounts for approximately 1 of every 3 deaths, or nearly 600,000 deaths each year.1 Almost 50 percent of the deaths attributed to myocardial infarction occur before the victims reach the hospital, and of the 500,000 people admitted each year for myocardial infarction, about 15 percent die during the hospitalization and another 7 to 10 percent die during the ensuing several years.2 , 3 A therapy for myocardial infarction that improved survival by even 20 percent would therefore affect tens of thousands of lives, and a similar benefit in the primary… © 1992, Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:1406 / 1416
页数:11
相关论文
共 182 条